SCHEMBL9004670

SCHEMBL9004670

O=C(NN=c1c(=O)c2ccccc2c1=O)Nc1ccc(F)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.55
KMT2A Q03164 5/20 0.55
SENP6 Q9GZR1 3/20 0.55
CASP3 P42574 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
SENP8 Q96LD8 2/20 0.55
SENP7 Q9BQF6 2/20 0.55
ALDH1A1 P00352 2/20 0.55
APAF1 O14727 1/20 0.55
TDP2 O95551 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
THRB P10828 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
NPC1 O15118 6/20 0.48
RAB9A P51151 5/20 0.48
HTT P42858 4/20 0.48
POLB P06746 2/20 0.48
MEN1 O00255 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8667830 0.88 SENP6 (0.61) MAPTKMT2ASENP6CASP3SMN1; SMN2
SCHEMBL8663571 0.87 RAB9A (0.45) MAPTKMT2ASENP6CASP3SMN1; SMN2
SCHEMBL8664300 0.86 SMN1; SMN2 (0.50) MAPTKMT2ASENP6CASP3SMN1; SMN2
SCHEMBL9004724 0.86 EPHX2 (0.57) MAPTKMT2ASENP6CASP3SMN1; SMN2
SCHEMBL9004705 0.85 MAOB (0.54) MAPTKMT2ASENP6CASP3SMN1; SMN2
SCHEMBL9004678 0.85 SMN1; SMN2 (0.51) MAPTKMT2ASENP6CASP3SMN1; SMN2
SCHEMBL9004631 0.85 SMN1; SMN2 (0.51) MAPTKMT2ASENP6CASP3SMN1; SMN2
SCHEMBL9227706 0.85 MAPT (0.51) MAPTKMT2ASENP6CASP3SMN1; SMN2
SCHEMBL9004624 0.85 RAB9A (0.50) MAPTKMT2ASENP6CASP3SMN1; SMN2
SCHEMBL9004665 0.84 ALDH1A1 (0.52) MAPTKMT2ASENP6CASP3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5571843-A Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof INNOTHERA (FR) 1996-11-05 US disclosed
EP-0566445-B1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA LAB SA (FR) 1996-02-07 EP disclosed
EP-0566445-A1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA (FR) 1993-10-20 EP disclosed
WO-1993020045-A1 INDAN-1,3-DIONE AND INDAN-1,2,3-TRIONE DERIVATIVES, PROCESSES FOR THE PREPARATION OF SAME AND THEIR APPLICATION AS THERAPEUTIC AGENTS INNOTHERA (FR) 1993-10-14 WO disclosed